Overview
Ki Chang practices practicing medicine in Wondu, Republic of Korea.
Their clinical expertise encompasses Renal Cell Carcinoma (RCC), Hydronephrosis, Lithotripsy, and Nephrectomy.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ki D. Chang
Is Ki D. Chang a top-rated expert for Lithotripsy?
MediFind is an objective health platform that identifies experts based on real-world data. Ki D. Chang is classified as an Experienced expert for Lithotripsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ki D. Chang participate in research or clinical trials?
Yes. Ki D. Chang has published 16 articles and abstracts on conditions like Lithotripsy. You can view a list of Ki D. Chang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HydronephrosisChang isExperienced. Learn about Hydronephrosis.
- LithotripsyChang isExperienced. Learn about Lithotripsy.
- NephrectomyChang isExperienced. Learn about Nephrectomy.
- ProstatectomyChang isExperienced. Learn about Prostatectomy.
- Renal Cell Carcinoma (RCC)Chang isExperienced. Learn about Renal Cell Carcinoma (RCC).